20 results on '"Stanford, R."'
Search Results
2. Prevalence of Nasal Symptoms in the United States: Findings from the Burden of Allergic Rhinitis in America Survey
3. Healthcare Resource Use and Costs for Rhinitis Patients Characterized by their Physicians: Medical and Pharmacy Claims Data Linked with Physician Survey Data
4. Fluticasone Furoate Nasal Spray (FFNS) has Negligible Impact on Health Plan Budgets: Output from a Budget Impact Model (BIM)
5. Validation of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q): A Patient Reported Outcomes (PRO) Questionnaire to measure Experience and Preference with Nasal Sprays
6. Development of Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q): A Questionnaire to measure Experience and Preference with Nasal Sprays
7. Performance of a Brief Self Administered Six Item Questionnaire to Test Rhinitis Control
8. Once-Daily Fluticasone Furoate Nasal Spray 110 mcg Improves Quality of Life in Subjects with Perennial Allergic Rhinitis
9. Once-Daily Fluticasone Furoate∗ Nasal Spray (FFNS) 110mcg Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the ragweed season ∗USAN approved name
10. Once-Daily Fluticasone Furoate∗ Nasal Spray (FFNS) Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the mountain cedar pollen season ∗USAN approved name
11. Nasal Spray Device And Formulation Attributes May Contribute To Stopping Treatment With Prescription Nasal Sprays
12. Subjective Effects of Allergic Rhinitis on Sleep Quality and Amount During the Winter
13. Symptom Burden During the Winter for Allergic and Non-allergic Rhinitis Sufferers
14. Rhinitis Symptom Sufferers Report a Significant Symptom Burden During an Allergy Season
15. Three year examination of trends in asthma-related utilization demonstrate significant variation in resource consumption
16. Budget model for estimating economic impact of fluticasone propionate/salmeterol via Diskus® in an adult asthma population
17. Seasonal variation in asthma-related hospital and ICU adminisions
18. 834 Patients on inhaled fluticasone 44 & 110 ug demonstrate significant reductions in both asthma and total health care costs while zafirlukast increases costs
19. 772 One year claims analysis demonstrates that fluticasone 44 and 110 reduces asthma-related hospitalizations, emergency rooms visits, and total asthma costs greater tha triamcinolone
20. Experimental production of granulomatous pneumonitis: Comparison of immunological and morphological sequelae with particulate and soluble antigens administered via the respiratory route
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.